Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Adenosine triphosphate may decrease weight loss and improve muscle strength in
patients with advanced solid tumors.
PURPOSE: Phase I trial to study the effectiveness of adenosine triphosphate in controlling
loss of weight and loss of muscle mass in patients who have advanced solid tumors.